Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.
Neurosci Appl – January 11, 2024
Source: PubMed Central
Summary
Despite growing interest in psychedelics for therapy, significant knowledge gaps currently impede their medical integration. An examination reveals inconsistencies in clinical trial data regarding optimal dosing and patient populations. Furthermore, varied regulatory frameworks across regions create hurdles for developing these promising treatments. Bridging these gaps is essential to unlock the full therapeutic potential and ensure safe access to these innovative medical options.
Abstract
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.